These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 30972903)

  • 21. Acoustic radiation force impulse-imaging and transient elastography for non-invasive assessment of liver fibrosis and steatosis in NAFLD.
    Friedrich-Rust M; Romen D; Vermehren J; Kriener S; Sadet D; Herrmann E; Zeuzem S; Bojunga J
    Eur J Radiol; 2012 Mar; 81(3):e325-31. PubMed ID: 22119555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Usefulness of Different Imaging Modalities in Evaluation of Patients with Non-Alcoholic Fatty Liver Disease.
    Grąt K; Grąt M; Rowiński O
    Biomedicines; 2020 Aug; 8(9):. PubMed ID: 32839409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatic Alanine Differentiates Nonalcoholic Steatohepatitis From Simple Steatosis in Humans and Mice: A Proton MR Spectroscopy Study With Long Echo Time.
    Kim TH; Jun HY; Kim KJ; Lee YH; Lee MS; Choi KH; Yun KJ; Jeong YY; Jun CH; Cho EY; Yoon KH
    J Magn Reson Imaging; 2017 Nov; 46(5):1298-1310. PubMed ID: 28225569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Role of Three-Dimensional Magnetic Resonance Elastography in the Diagnosis of Nonalcoholic Steatohepatitis in Obese Patients Undergoing Bariatric Surgery.
    Allen AM; Shah VH; Therneau TM; Venkatesh SK; Mounajjed T; Larson JJ; Mara KC; Schulte PJ; Kellogg TA; Kendrick ML; McKenzie TJ; Greiner SM; Li J; Glaser KJ; Wells ML; Chen J; Ehman RL; Yin M
    Hepatology; 2020 Feb; 71(2):510-521. PubMed ID: 30582669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Application of Ultrasound and Shear Wave Elastography Imaging in a Rat Model of NAFLD/NASH.
    Morin J; Swanson TA; Rinaldi A; Boucher M; Ross T; Hirenallur-Shanthappa D
    J Vis Exp; 2021 Apr; (170):. PubMed ID: 33970131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation and comparison of six noninvasive tests for prediction of significant or advanced fibrosis in nonalcoholic fatty liver disease.
    Staufer K; Halilbasic E; Spindelboeck W; Eilenberg M; Prager G; Stadlbauer V; Posch A; Munda P; Marculescu R; Obermayer-Pietsch B; Stift J; Lackner C; Trauner M; Stauber RE
    United European Gastroenterol J; 2019 Oct; 7(8):1113-1123. PubMed ID: 31662868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Noninvasive imaging assessment of non-alcoholic fatty liver disease: focus on liver scintigraphy.
    Tovo CV; de Mattos AZ; Coral GP; Branco FS; Suwa E; de Mattos AA
    World J Gastroenterol; 2015 Apr; 21(15):4432-9. PubMed ID: 25914452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discrimination of Nonalcoholic Steatohepatitis Using Transient Elastography in Patients with Nonalcoholic Fatty Liver Disease.
    Lee HW; Park SY; Kim SU; Jang JY; Park H; Kim JK; Lee CK; Chon YE; Han KH
    PLoS One; 2016; 11(6):e0157358. PubMed ID: 27284700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accuracy of Ultrasonography vs. Elastography in Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review.
    Geethakumari P; Kampa P; Parchuri R; Bhandari R; Alnasser AR; Akram A; Kar S; Osman F; Mashat GD; Tran HH; Urgessa NA; Yu AK
    Cureus; 2022 Oct; 14(10):e29967. PubMed ID: 36381908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparing point shear wave elastography (ElastPQ) and transient elastography for diagnosis of fibrosis stage in non-alcoholic fatty liver disease.
    Leong WL; Lai LL; Nik Mustapha NR; Vijayananthan A; Rahmat K; Mahadeva S; Chan WK
    J Gastroenterol Hepatol; 2020 Jan; 35(1):135-141. PubMed ID: 31310032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-utility analysis of nonalcoholic steatohepatitis screening.
    Zhang E; Wartelle-Bladou C; Lepanto L; Lachaine J; Cloutier G; Tang A
    Eur Radiol; 2015 Nov; 25(11):3282-94. PubMed ID: 25994191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluating feasibility and accuracy of non-invasive tests for nonalcoholic fatty liver disease in severe and morbid obesity.
    Ooi GJ; Earnest A; Kemp WW; Burton PR; Laurie C; Majeed A; Johnson N; McLean C; Roberts SK; Brown WA
    Int J Obes (Lond); 2018 Nov; 42(11):1900-1911. PubMed ID: 29463916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Review article: the diagnosis of non-alcoholic fatty liver disease -- availability and accuracy of non-invasive methods.
    Festi D; Schiumerini R; Marzi L; Di Biase AR; Mandolesi D; Montrone L; Scaioli E; Bonato G; Marchesini-Reggiani G; Colecchia A
    Aliment Pharmacol Ther; 2013 Feb; 37(4):392-400. PubMed ID: 23278163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of artificial intelligence techniques for non-alcoholic fatty liver disease diagnosis: A systematic review (2005-2023).
    Zamanian H; Shalbaf A; Zali MR; Khalaj AR; Dehghan P; Tabesh M; Hatami B; Alizadehsani R; Tan RS; Acharya UR
    Comput Methods Programs Biomed; 2024 Feb; 244():107932. PubMed ID: 38008040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
    Eddowes PJ; Sasso M; Allison M; Tsochatzis E; Anstee QM; Sheridan D; Guha IN; Cobbold JF; Deeks JJ; Paradis V; Bedossa P; Newsome PN
    Gastroenterology; 2019 May; 156(6):1717-1730. PubMed ID: 30689971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
    Eslami L; Merat S; Malekzadeh R; Nasseri-Moghaddam S; Aramin H
    Cochrane Database Syst Rev; 2013 Dec; (12):CD008623. PubMed ID: 24374462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decision analytic model of the diagnostic pathways for patients with suspected non-alcoholic fatty liver disease using non-invasive transient elastography and multiparametric magnetic resonance imaging.
    Blake L; Duarte RV; Cummins C
    BMJ Open; 2016 Sep; 6(9):e010507. PubMed ID: 27650757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Imaging biomarkers for steatohepatitis and fibrosis detection in non-alcoholic fatty liver disease.
    Gallego-Durán R; Cerro-Salido P; Gomez-Gonzalez E; Pareja MJ; Ampuero J; Rico MC; Aznar R; Vilar-Gomez E; Bugianesi E; Crespo J; González-Sánchez FJ; Aparcero R; Moreno I; Soto S; Arias-Loste MT; Abad J; Ranchal I; Andrade RJ; Calleja JL; Pastrana M; Iacono OL; Romero-Gómez M
    Sci Rep; 2016 Aug; 6():31421. PubMed ID: 27514671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnosis and Evaluation of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Including Noninvasive Biomarkers and Transient Elastography.
    Tsai E; Lee TP
    Clin Liver Dis; 2018 Feb; 22(1):73-92. PubMed ID: 29128062
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acoustic radiation force impulse elastography as compared to transient elastography and liver biopsy in patients with chronic hepatopathies.
    Sporea I; Sirli RL; Deleanu A; Popescu A; Focsa M; Danila M; Tudora A
    Ultraschall Med; 2011 Jan; 32 Suppl 1():S46-52. PubMed ID: 20603783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.